Loading...
|
Please use this identifier to cite or link to this item:
http://140.112.114.62/handle/246246/170430
|
| Title: | Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status |
| Authors: | 蘇文彬;楊志新;余忠仁;楊泮池;施金元;許駿;楊志新
SU, WEN-PIN;YANG, CHIH-HSIN;YU, CHONG-JEN;YANG, PAN-CHYR;SHIH, JIN-YUAN;HSU, CHIUN |
| Contributors: | 腫瘤醫學部 |
| Date: | 2005 |
| Issue Date: | 2009-10-13T15:21:13Z
|
| Abstract: | Background and Purpose: Gefitinib is effective in the treatment of advanced non small tell lung cancer (NSCLC) However, most studies have only investigated patients who have good performance status or are, evaluable. This study evaluated the efficacy of gefitinib in a consecutive series of patients with NSCLC. Methods: The treatment response of all gefitinib-trated NSCLC patients from November 2001 to September 2003 at a single medical institute was retrospectively evaluated All patients receiving at least 1 dose of gefitinib during the study period were included. Results: A total of 66 NSCLC patients were treated including 22 patients with Eastern Clinical Oncology Group performance status 3 or 4 No prior chemotherapy had been given in 14 patients because of their personal preference or poor general condition The duration of treatment ranged from 1 day to 19.3 months (median 2.5 months) The partial remission rate was 15.2% and the stable disease rate was 25. 8%. The median survival for all patients was 5.9 months and the 1 year survival rate was 27.9% Symptom improvement and response correlated well to survival Female gender non smoking status and performance status of 0-2 were associated with better survival The disease control rate was 22.7% in patients with performance Status of 3-4. Conclusions: Gefitinib can be recommended for the treatment of advanced NSCLC in patients for whom standard chemotherapy is not an option. Further study is required to determin the optimal selection criteria of patients and the timing of starting therapy. |
| Relation: | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION v.104 n.8 pp.557-562 |
| Appears in Collections: | [附設醫院腫瘤醫學部] 期刊論文
|
Files in This Item:
There are no files associated with this item.
|
All items in NTUR are protected by copyright, with all rights reserved.
|
